Literature DB >> 12840851

[The experimental investigation on the preventive effects of API0134 against the re-occlusion of coronary arteries after therapeutic thrombolysis in dogs].

S Li1, H Zhao, Z Guo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 12840851     DOI： 10.1007/bf02886888

Source DB:  PubMed          Journal:  J Tongji Med Univ        ISSN： 0257-716X


× No keyword cloud information.
  12 in total

Review 1.  Platelets and thrombolytic therapy.

Authors:  B S Coller
Journal:  N Engl J Med       Date:  1990-01-04       Impact factor: 91.245

2.  ESPRIT: a European study of the prevention of reocclusion after initial thrombolysis with duteplase in acute myocardial infarction.

Authors:  A D Malcolm; M Keltai; M J Walsh
Journal:  Eur Heart J       Date:  1996-10       Impact factor: 29.983

3.  Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.

Authors:  J H Chesebro; G Knatterud; R Roberts; J Borer; L S Cohen; J Dalen; H T Dodge; C K Francis; D Hillis; P Ludbrook
Journal:  Circulation       Date:  1987-07       Impact factor: 29.690

4.  Importance of reperfusion on thromboxane A2 metabolite excretion after thrombolysis.

Authors:  A G Rebuzzi; A Natale; C Bianchi; S Albanese; G A Lanza; E Coppola; G Ciabattoni
Journal:  Am Heart J       Date:  1992-03       Impact factor: 4.749

5.  Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group.

Authors: 
Journal:  Lancet       Date:  1988-08-13       Impact factor: 79.321

6.  Increased production of thromboxane A2 by coronary arteries after thrombolysis.

Authors:  T G Saldeen; P Saldeen; W W Nichols; D L Lawson; F A Nicolini; J L Mehta
Journal:  Am Heart J       Date:  1993-02       Impact factor: 4.749

7.  Effects of heparin, aspirin and a synthetic platelet glycoprotein IIb-IIIa receptor antagonist (Ro 43-5054) on coronary artery reperfusion and reocclusion after thrombolysis with tissue-type plasminogen activator in the dog.

Authors:  S P Roux; T B Tschopp; H Kuhn; B Steiner; P Hadváry
Journal:  J Pharmacol Exp Ther       Date:  1993-01       Impact factor: 4.030

8.  Comparison of the inhibitory effects of the TXA2 receptor antagonist, vapiprost, and other antiplatelet drugs on arterial thrombosis in rats: possible role of TXA2.

Authors:  Y Takiguchi; K Wada; M Nakashima
Journal:  Thromb Haemost       Date:  1992-10-05       Impact factor: 5.249

9.  Comparison of antithrombotic effects of GPIIb-IIIa receptor antagonist and TXA2 receptor antagonist in the guinea-pig thrombosis model: possible role of TXA2 in reocclusion after thrombolysis.

Authors:  Y Takiguchi; F Asai; K Wada; M Nakashima
Journal:  Thromb Haemost       Date:  1995-04       Impact factor: 5.249

10.  Is vasospasm related to platelet deposition? Relationship in a porcine preparation of arterial injury in vivo.

Authors:  J Y Lam; J H Chesebro; P M Steele; L Badimon; V Fuster
Journal:  Circulation       Date:  1987-01       Impact factor: 29.690
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.